Pancreatic Cancer Research

ResearcherHenan Provincial People's HospitalActive in the last 2 years

Hai Li

Matched on ORCID iD 0009-0000-6111-7729; OpenAlex author ID A5030308308.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. PLK1 inhibition enhances gemcitabine-induced apoptosis through PLK1-dependent ERK1/2-Bim and AKT1/Noxa signals in pancreatic cancer cells. Co-author DOI 10.1007/s12032-025-03062-z↗
  2. STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice. First author DOI 10.1371/journal.pone.0025941↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Bing Lü · 1 shared paper, 2025
  2. Yadong Wang · 1 shared paper, 2025
  3. Chen Huang · 1 shared paper, 2011
  4. Zheng Qiu · 1 shared paper, 2011

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.